HealthSonix’ Research Study Shows Clinically Significant Pain Reduction With Osteoarthritis Patients

IRVINE, CA -- (MARKET WIRE) -- December 13, 2006 -- HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) today announced the completion of an AquaSonix Therapy "Guelph" clinical research study.
MORE ON THIS TOPIC